TSPAN4 and migrasomes in atherosclerosis regression correlated to myocardial infarction and pan-cancer progression

Yue Zheng1,2,3,4, Yuheng Lang2,3,4,5, Bingcai Qi2,3,4,5

  • 1School of Medicine, Nankai University, Tianjin, Binhai, China.

Cell Adhesion & Migration
|December 13, 2022
PubMed

Insights

Tetraspanin 4 (TSPAN4) plays a key role in migrasome formation. Its aberrant expression is linked to atherosclerosis and cancer progression, suggesting potential therapeutic interventions.

Area of Science:

  • Cell Biology
  • Immunology
  • Cardiovascular Research

Background:

  • Migrasome formation involves tetraspanin macrodomains and tetraspanin 4 (TSPAN4).
  • The precise physiological roles of TSPAN4 in migrasomes remain largely unexplored.

Purpose of the Study:

  • To investigate the expression patterns and functional significance of TSPAN4 in macrophages.
  • To explore the association of TSPAN4 with atherosclerosis and cancer progression.

Main Methods:

  • Analysis of TSPAN4 expression in macrophages using single-cell sequencing, GEO datasets, and TCGA database.
  • Evaluation of TSPAN4 upregulation in mouse models of myocardial infarction (MI).
  • Correlation analysis of TSPAN4 expression with atherosclerosis markers and tumor-associated macrophages.

Main Results:

  • TSPAN4 expression is significantly associated with atherosclerosis regression-related macrophages, intraplaque hemorrhage, and ruptured plaques.
  • TSPAN4 is upregulated in both spontaneous and inducible mouse models of MI.
  • Elevated TSPAN4 expression correlates strongly with tumor-associated macrophages.

Conclusions:

  • Aberrant TSPAN4 expression is critically implicated in the progression of atherosclerosis and pan-cancer.
  • Targeting TSPAN4 and migrasomes presents a potential therapeutic strategy to improve patient outcomes in cardiovascular diseases and cancer.